Position in ARGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,085,378
+$2,032,779 QoQ
Shares Held
7,637
+10.4% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#136
of 504 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Federation des caisses Desjardins du Quebec holds $61,128,076 across 154 Biotechnology names. ARGX ranks #2 (11.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
20,094 | $9,981,291 | |
| 2 | ARGX |
Argenx SE
This page
|
7,637 | $7,085,378 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
10,915 | $6,805,937 | |
| 4 | INCY |
Incyte Corp
|
57,354 | $6,501,647 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
16,951 | $3,174,581 | |
| 6 | MRNA |
Moderna, Inc.
|
41,572 | $2,911,286 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
8,591 | $2,586,147 | |
| 8 | TECH |
BIO-TECHNE Corp
|
32,626 | $2,305,026 |
All Filings in ARGX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,085,378 | 7,637 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $5,052,599 | 6,919 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $5,200,434 | 6,184 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $4,803,727 | 6,513 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,315,588 | 6,015 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,728,837 | 2,921 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $873,915 | 1,421 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $570,810 | 1,053 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $412,408 | 959 | Shares | Defined | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||